Does ELOSULFASE ALFA Cause Hyperhidrosis? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Hyperhidrosis have been filed in association with ELOSULFASE ALFA (VIMIZIM). This represents 0.8% of all adverse event reports for ELOSULFASE ALFA.
40
Reports of Hyperhidrosis with ELOSULFASE ALFA
0.8%
of all ELOSULFASE ALFA reports
2
Deaths
9
Hospitalizations
How Dangerous Is Hyperhidrosis From ELOSULFASE ALFA?
Of the 40 reports, 2 (5.0%) resulted in death, 9 (22.5%) required hospitalization, and 3 (7.5%) were considered life-threatening.
Is Hyperhidrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOSULFASE ALFA. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does ELOSULFASE ALFA Cause?
Pyrexia (682)
Cough (318)
Vomiting (308)
Malaise (282)
Headache (242)
Dyspnoea (216)
Nausea (212)
Pain (205)
Nasopharyngitis (183)
Fatigue (177)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which ELOSULFASE ALFA Alternatives Have Lower Hyperhidrosis Risk?
ELOSULFASE ALFA vs ELOTUZUMAB
ELOSULFASE ALFA vs ELOXATIN
ELOSULFASE ALFA vs ELRANATAMAB
ELOSULFASE ALFA vs ELRANATAMAB-BCMM
ELOSULFASE ALFA vs ELTROMBOPAG